EMEA (Europe, Middle East and Africa) Age Related Macular Degeneration Drug Market Report 2018

January 2018 | 113 pages | ID: EB82DD3B84CEN
QYResearch

Abstracts

In this report, the EMEA Age Related Macular Degeneration Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Age Related Macular Degeneration Drug for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Age Related Macular Degeneration Drug market competition by top manufacturers/players, with Age Related Macular Degeneration Drug sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Applied Genetic Technologies Corp
• Astellas Pharma Inc
• Benitec Biopharma Ltd
• Biokine Therapeutics Ltd
• Crinetics Pharmaceuticals Inc
• Critical Pharmaceuticals Ltd
• Daiichi Sankyo Company Ltd
• Diffusion Pharmaceuticals Inc
• Dong-A Socio Holdings Co Ltd
• Eleven Biotherapeutics Inc
• Elsalys Biotech SAS
• Lupin Ltd
• M's Science Corp
• Mabion SA
• MacuCLEAR Inc

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Lucentis
• Eylea
• Avastin
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Clinic
• Hospital
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Age Related Macular Degeneration Drug Market Report 2017

1 AGE RELATED MACULAR DEGENERATION DRUG OVERVIEW

1.1 Product Overview and Scope of Age Related Macular Degeneration Drug
1.2 Classification of Age Related Macular Degeneration Drug
  1.2.1 EMEA Age Related Macular Degeneration Drug Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Age Related Macular Degeneration Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Lucentis
  1.2.4 Eylea
  1.2.5 Avastin
  1.2.6 Others
1.3 EMEA Age Related Macular Degeneration Drug Market by Application/End Users
  1.3.1 EMEA Age Related Macular Degeneration Drug Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Clinic
  1.3.3 Hospital
  1.3.4 Others
1.4 EMEA Age Related Macular Degeneration Drug Market by Region
  1.4.1 EMEA Age Related Macular Degeneration Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Age Related Macular Degeneration Drug (2012-2022)
  1.5.1 EMEA Age Related Macular Degeneration Drug Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2022)

2 EMEA AGE RELATED MACULAR DEGENERATION DRUG COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Age Related Macular Degeneration Drug Market Competition by Players/Manufacturers
  2.1.1 EMEA Age Related Macular Degeneration Drug Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Age Related Macular Degeneration Drug Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Age Related Macular Degeneration Drug Sale Price by Players (2012-2017)
2.2 EMEA Age Related Macular Degeneration Drug (Volume and Value) by Type/Product Category
  2.2.1 EMEA Age Related Macular Degeneration Drug Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Age Related Macular Degeneration Drug Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Age Related Macular Degeneration Drug Sale Price by Type (2012-2017)
2.3 EMEA Age Related Macular Degeneration Drug (Volume) by Application
2.4 EMEA Age Related Macular Degeneration Drug (Volume and Value) by Region
  2.4.1 EMEA Age Related Macular Degeneration Drug Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Age Related Macular Degeneration Drug Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Age Related Macular Degeneration Drug Sales Price by Region (2012-2017)

3 EUROPE AGE RELATED MACULAR DEGENERATION DRUG (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Age Related Macular Degeneration Drug Sales and Value (2012-2017)
  3.1.1 Europe Age Related Macular Degeneration Drug Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2017)
3.2 Europe Age Related Macular Degeneration Drug Sales and Market Share by Type
3.3 Europe Age Related Macular Degeneration Drug Sales and Market Share by Application
3.4 Europe Age Related Macular Degeneration Drug Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Age Related Macular Degeneration Drug Sales Volume by Countries (2012-2017)
  3.4.2 Europe Age Related Macular Degeneration Drug Revenue by Countries (2012-2017)
  3.4.3 Germany Age Related Macular Degeneration Drug Sales and Growth Rate (2012-2017)
  3.4.4 France Age Related Macular Degeneration Drug Sales and Growth Rate (2012-2017)
  3.4.5 UK Age Related Macular Degeneration Drug Sales and Growth Rate (2012-2017)
  3.4.6 Russia Age Related Macular Degeneration Drug Sales and Growth Rate (2012-2017)
  3.4.7 Italy Age Related Macular Degeneration Drug Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Age Related Macular Degeneration Drug Sales and Growth Rate (2012-2017)

4 MIDDLE EAST AGE RELATED MACULAR DEGENERATION DRUG (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Age Related Macular Degeneration Drug Sales and Value (2012-2017)
  4.1.1 Middle East Age Related Macular Degeneration Drug Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2017)
4.2 Middle East Age Related Macular Degeneration Drug Sales and Market Share by Type
4.3 Middle East Age Related Macular Degeneration Drug Sales and Market Share by Application
4.4 Middle East Age Related Macular Degeneration Drug Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Age Related Macular Degeneration Drug Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Age Related Macular Degeneration Drug Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Age Related Macular Degeneration Drug Sales and Growth Rate (2012-2017)
  4.4.4 Israel Age Related Macular Degeneration Drug Sales and Growth Rate (2012-2017)
  4.4.5 UAE Age Related Macular Degeneration Drug Sales and Growth Rate (2012-2017)
  4.4.6 Iran Age Related Macular Degeneration Drug Sales and Growth Rate (2012-2017)

5 AFRICA AGE RELATED MACULAR DEGENERATION DRUG (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Age Related Macular Degeneration Drug Sales and Value (2012-2017)
  5.1.1 Africa Age Related Macular Degeneration Drug Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2017)
5.2 Africa Age Related Macular Degeneration Drug Sales and Market Share by Type
5.3 Africa Age Related Macular Degeneration Drug Sales and Market Share by Application
5.4 Africa Age Related Macular Degeneration Drug Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Age Related Macular Degeneration Drug Sales Volume by Countries (2012-2017)
  5.4.2 Africa Age Related Macular Degeneration Drug Revenue by Countries (2012-2017)
  5.4.3 South Africa Age Related Macular Degeneration Drug Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Age Related Macular Degeneration Drug Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Age Related Macular Degeneration Drug Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Age Related Macular Degeneration Drug Sales and Growth Rate (2012-2017)

6 EMEA AGE RELATED MACULAR DEGENERATION DRUG MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Applied Genetic Technologies Corp
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Age Related Macular Degeneration Drug Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Applied Genetic Technologies Corp Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Astellas Pharma Inc
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Age Related Macular Degeneration Drug Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Astellas Pharma Inc Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Benitec Biopharma Ltd
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Age Related Macular Degeneration Drug Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Benitec Biopharma Ltd Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Biokine Therapeutics Ltd
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Age Related Macular Degeneration Drug Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Biokine Therapeutics Ltd Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Crinetics Pharmaceuticals Inc
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Age Related Macular Degeneration Drug Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Crinetics Pharmaceuticals Inc Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Critical Pharmaceuticals Ltd
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Age Related Macular Degeneration Drug Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Critical Pharmaceuticals Ltd Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Daiichi Sankyo Company Ltd
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Age Related Macular Degeneration Drug Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Daiichi Sankyo Company Ltd Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Diffusion Pharmaceuticals Inc
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Age Related Macular Degeneration Drug Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Diffusion Pharmaceuticals Inc Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Dong-A Socio Holdings Co Ltd
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Age Related Macular Degeneration Drug Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Dong-A Socio Holdings Co Ltd Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Eleven Biotherapeutics Inc
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Age Related Macular Degeneration Drug Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Eleven Biotherapeutics Inc Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Elsalys Biotech SAS
6.12 Lupin Ltd
6.13 M's Science Corp
6.14 Mabion SA
6.15 MacuCLEAR Inc

7 AGE RELATED MACULAR DEGENERATION DRUG MANUFACTURING COST ANALYSIS

7.1 Age Related Macular Degeneration Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Age Related Macular Degeneration Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Age Related Macular Degeneration Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Age Related Macular Degeneration Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA AGE RELATED MACULAR DEGENERATION DRUG MARKET FORECAST (2017-2022)

11.1 EMEA Age Related Macular Degeneration Drug Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Age Related Macular Degeneration Drug Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Age Related Macular Degeneration Drug Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Age Related Macular Degeneration Drug Price and Trend Forecast (2017-2022)
11.2 EMEA Age Related Macular Degeneration Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Age Related Macular Degeneration Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Age Related Macular Degeneration Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Age Related Macular Degeneration Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Age Related Macular Degeneration Drug Sales Forecast by Type (2017-2022)
11.7 EMEA Age Related Macular Degeneration Drug Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Age Related Macular Degeneration Drug
Figure EMEA Age Related Macular Degeneration Drug Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Age Related Macular Degeneration Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Lucentis Product Picture
Figure Eylea Product Picture
Figure Avastin Product Picture
Figure Others Product Picture
Figure EMEA Age Related Macular Degeneration Drug Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Age Related Macular Degeneration Drug by Application in 2016
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Age Related Macular Degeneration Drug Market Size (Million USD) by Region (2012-2022)
Figure Europe Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Age Related Macular Degeneration Drug Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Age Related Macular Degeneration Drug Revenue (Million USD) Status and Forecast by Countries
Figure Africa Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Age Related Macular Degeneration Drug Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Age Related Macular Degeneration Drug Sales Volume and Growth Rate (2012-2022)
Figure EMEA Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Age Related Macular Degeneration Drug Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Age Related Macular Degeneration Drug Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Age Related Macular Degeneration Drug Sales Share by Players (2012-2017)
Figure 2016 Age Related Macular Degeneration Drug Sales Share by Players
Figure 2017 Age Related Macular Degeneration Drug Sales Share by Players
Figure EMEA Age Related Macular Degeneration Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Age Related Macular Degeneration Drug Revenue (Million USD) by Players (2012-2017)
Table EMEA Age Related Macular Degeneration Drug Revenue Share by Players (2012-2017)
Table 2016 EMEA Age Related Macular Degeneration Drug Revenue Share by Players
Table 2017 EMEA Age Related Macular Degeneration Drug Revenue Share by Players
Table EMEA Age Related Macular Degeneration Drug Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Age Related Macular Degeneration Drug Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Age Related Macular Degeneration Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Age Related Macular Degeneration Drug by Type (2012-2017)
Figure EMEA Age Related Macular Degeneration Drug Sales Market Share by Type (2012-2017)
Table EMEA Age Related Macular Degeneration Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Age Related Macular Degeneration Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Age Related Macular Degeneration Drug by Type in 2016
Table EMEA Age Related Macular Degeneration Drug Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Age Related Macular Degeneration Drug Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Age Related Macular Degeneration Drug Sales Share by Application (2012-2017)
Figure Sales Market Share of Age Related Macular Degeneration Drug by Application (2012-2017)
Figure EMEA Age Related Macular Degeneration Drug Sales Market Share by Application in 2016
Table EMEA Age Related Macular Degeneration Drug Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Age Related Macular Degeneration Drug Sales Share by Region (2012-2017)
Figure Sales Market Share of Age Related Macular Degeneration Drug by Region (2012-2017)
Figure EMEA Age Related Macular Degeneration Drug Sales Market Share in 2016
Table EMEA Age Related Macular Degeneration Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Age Related Macular Degeneration Drug Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Age Related Macular Degeneration Drug by Region (2012-2017)
Figure EMEA Age Related Macular Degeneration Drug Revenue Market Share Regions in 2016
Table EMEA Age Related Macular Degeneration Drug Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2017)
Table Europe Age Related Macular Degeneration Drug Sales (K Pcs) by Type (2012-2017)
Table Europe Age Related Macular Degeneration Drug Market Share by Type (2012-2017)
Figure Europe Age Related Macular Degeneration Drug Market Share by Type in 2016
Table Europe Age Related Macular Degeneration Drug Sales (K Pcs) by Application (2012-2017)
Table Europe Age Related Macular Degeneration Drug Market Share by Application (2012-2017)
Figure Europe Age Related Macular Degeneration Drug Market Share by Application in 2016
Table Europe Age Related Macular Degeneration Drug Sales (K Pcs) by Countries (2012-2017)
Table Europe Age Related Macular Degeneration Drug Sales Market Share by Countries (2012-2017)
Figure Europe Age Related Macular Degeneration Drug Sales Market Share by Countries (2012-2017)
Figure Europe Age Related Macular Degeneration Drug Sales Market Share by Countries in 2016
Table Europe Age Related Macular Degeneration Drug Revenue (Million USD) by Countries (2012-2017)
Table Europe Age Related Macular Degeneration Drug Revenue Market Share by Countries (2012-2017)
Figure Europe Age Related Macular Degeneration Drug Revenue Market Share by Countries (2012-2017)
Figure Europe Age Related Macular Degeneration Drug Revenue Market Share by Countries in 2016
Figure Germany Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Age Related Macular Degeneration Drug Sales (K Pcs) by Type (2012-2017)
Table Middle East Age Related Macular Degeneration Drug Market Share by Type (2012-2017)
Figure Middle East Age Related Macular Degeneration Drug Market Share by Type (2012-2017)
Table Middle East Age Related Macular Degeneration Drug Sales (K Pcs) by Applications (2012-2017)
Table Middle East Age Related Macular Degeneration Drug Market Share by Applications (2012-2017)
Figure Middle East Age Related Macular Degeneration Drug Sales Market Share by Application in 2016
Table Middle East Age Related Macular Degeneration Drug Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Age Related Macular Degeneration Drug Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Age Related Macular Degeneration Drug Sales Volume Market Share by Countries in 2016
Table Middle East Age Related Macular Degeneration Drug Revenue (Million USD) by Countries (2012-2017)
Table Middle East Age Related Macular Degeneration Drug Revenue Market Share by Countries (2012-2017)
Figure Middle East Age Related Macular Degeneration Drug Revenue Market Share by Countries (2012-2017)
Figure Middle East Age Related Macular Degeneration Drug Revenue Market Share by Countries in 2016
Figure Saudi Arabia Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Age Related Macular Degeneration Drug Sales (K Pcs) by Type (2012-2017)
Table Africa Age Related Macular Degeneration Drug Sales Market Share by Type (2012-2017)
Figure Africa Age Related Macular Degeneration Drug Sales Market Share by Type (2012-2017)
Figure Africa Age Related Macular Degeneration Drug Sales Market Share by Type in 2016
Table Africa Age Related Macular Degeneration Drug Sales (K Pcs) by Application (2012-2017)
Table Africa Age Related Macular Degeneration Drug Sales Market Share by Application (2012-2017)
Figure Africa Age Related Macular Degeneration Drug Sales Market Share by Application (2012-2017)
Table Africa Age Related Macular Degeneration Drug Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Age Related Macular Degeneration Drug Sales Market Share by Countries (2012-2017)
Figure Africa Age Related Macular Degeneration Drug Sales Market Share by Countries (2012-2017)
Figure Africa Age Related Macular Degeneration Drug Sales Market Share by Countries in 2016
Table Africa Age Related Macular Degeneration Drug Revenue (Million USD) by Countries (2012-2017)
Table Africa Age Related Macular Degeneration Drug Revenue Market Share by Countries (2012-2017)
Figure Africa Age Related Macular Degeneration Drug Revenue Market Share by Countries (2012-2017)
Figure Africa Age Related Macular Degeneration Drug Revenue Market Share by Countries in 2016
Figure South Africa Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Table Applied Genetic Technologies Corp Age Related Macular Degeneration Drug Basic Information List
Table Applied Genetic Technologies Corp Age Related Macular Degeneration Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Applied Genetic Technologies Corp Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Applied Genetic Technologies Corp Age Related Macular Degeneration Drug Sales Market Share in EMEA (2012-2017)
Figure Applied Genetic Technologies Corp Age Related Macular Degeneration Drug Revenue Market Share in EMEA (2012-2017)
Table Astellas Pharma Inc Age Related Macular Degeneration Drug Basic Information List
Table Astellas Pharma Inc Age Related Macular Degeneration Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Astellas Pharma Inc Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Astellas Pharma Inc Age Related Macular Degeneration Drug Sales Market Share in EMEA (2012-2017)
Figure Astellas Pharma Inc Age Related Macular Degeneration Drug Revenue Market Share in EMEA (2012-2017)
Table Benitec Biopharma Ltd Age Related Macular Degeneration Drug Basic Information List
Table Benitec Biopharma Ltd Age Related Macular Degeneration Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Benitec Biopharma Ltd Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benitec Biopharma Ltd Age Related Macular Degeneration Drug Sales Market Share in EMEA (2012-2017)
Figure Benitec Biopharma Ltd Age Related Macular Degeneration Drug Revenue Market Share in EMEA (2012-2017)
Table Biokine Therapeutics Ltd Age Related Macular Degeneration Drug Basic Information List
Table Biokine Therapeutics Ltd Age Related Macular Degeneration Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Biokine Therapeutics Ltd Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Biokine Therapeutics Ltd Age Related Macular Degeneration Drug Sales Market Share in EMEA (2012-2017)
Figure Biokine Therapeutics Ltd Age Related Macular Degeneration Drug Revenue Market Share in EMEA (2012-2017)
Table Crinetics Pharmaceuticals Inc Age Related Macular Degeneration Drug Basic Information List
Table Crinetics Pharmaceuticals Inc Age Related Macular Degeneration Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Crinetics Pharmaceuticals Inc Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Crinetics Pharmaceuticals Inc Age Related Macular Degeneration Drug Sales Market Share in EMEA (2012-2017)
Figure Crinetics Pharmaceuticals Inc Age Related Macular Degeneration Drug Revenue Market Share in EMEA (2012-2017)
Table Critical Pharmaceuticals Ltd Age Related Macular Degeneration Drug Basic Information List
Table Critical Pharmaceuticals Ltd Age Related Macular Degeneration Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Critical Pharmaceuticals Ltd Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Critical Pharmaceuticals Ltd Age Related Macular Degeneration Drug Sales Market Share in EMEA (2012-2017)
Figure Critical Pharmaceuticals Ltd Age Related Macular Degeneration Drug Revenue Market Share in EMEA (2012-2017)
Table Daiichi Sankyo Company Ltd Age Related Macular Degeneration Drug Basic Information List
Table Daiichi Sankyo Company Ltd Age Related Macular Degeneration Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Daiichi Sankyo Company Ltd Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Daiichi Sankyo Company Ltd Age Related Macular Degeneration Drug Sales Market Share in EMEA (2012-2017)
Figure Daiichi Sankyo Company Ltd Age Related Macular Degeneration Drug Revenue Market Share in EMEA (2012-2017)
Table Diffusion Pharmaceuticals Inc Age Related Macular Degeneration Drug Basic Information List
Table Diffusion Pharmaceuticals Inc Age Related Macular Degeneration Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Diffusion Pharmaceuticals Inc Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Diffusion Pharmaceuticals Inc Age Related Macular Degeneration Drug Sales Market Share in EMEA (2012-2017)
Figure Diffusion Pharmaceuticals Inc Age Related Macular Degeneration Drug Revenue Market Share in EMEA (2012-2017)
Table Dong-A Socio Holdings Co Ltd Age Related Macular Degeneration Drug Basic Information List
Table Dong-A Socio Holdings Co Ltd Age Related Macular Degeneration Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Dong-A Socio Holdings Co Ltd Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Dong-A Socio Holdings Co Ltd Age Related Macular Degeneration Drug Sales Market Share in EMEA (2012-2017)
Figure Dong-A Socio Holdings Co Ltd Age Related Macular Degeneration Drug Revenue Market Share in EMEA (2012-2017)
Table Eleven Biotherapeutics Inc Age Related Macular Degeneration Drug Basic Information List
Table Eleven Biotherapeutics Inc Age Related Macular Degeneration Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eleven Biotherapeutics Inc Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Eleven Biotherapeutics Inc Age Related Macular Degeneration Drug Sales Market Share in EMEA (2012-2017)
Figure Eleven Biotherapeutics Inc Age Related Macular Degeneration Drug Revenue Market Share in EMEA (2012-2017)
Table Elsalys Biotech SAS Age Related Macular Degeneration Drug Basic Information List
Table Lupin Ltd Age Related Macular Degeneration Drug Basic Information List
Table M's Science Corp Age Related Macular Degeneration Drug Basic Information List
Table Mabion SA Age Related Macular Degeneration Drug Basic Information List
Table MacuCLEAR Inc Age Related Macular Degeneration Drug Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Age Related Macular Degeneration Drug
Figure Manufacturing Process Analysis of Age Related Macular Degeneration Drug
Figure Age Related Macular Degeneration Drug Industrial Chain Analysis
Table Raw Materials Sources of Age Related Macular Degeneration Drug Major Manufacturers in 2016
Table Major Buyers of Age Related Macular Degeneration Drug
Table Distributors/Traders List
Figure EMEA Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Age Related Macular Degeneration Drug Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Age Related Macular Degeneration Drug Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Age Related Macular Degeneration Drug Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Age Related Macular Degeneration Drug Sales Market Share Forecast by Region (2017-2022)
Table EMEA Age Related Macular Degeneration Drug Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Age Related Macular Degeneration Drug Revenue Market Share Forecast by Region (2017-2022)
Table Europe Age Related Macular Degeneration Drug Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Age Related Macular Degeneration Drug Sales Market Share Forecast by Countries (2017-2022)
Table Europe Age Related Macular Degeneration Drug Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Age Related Macular Degeneration Drug Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Age Related Macular Degeneration Drug Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Age Related Macular Degeneration Drug Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Age Related Macular Degeneration Drug Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Age Related Macular Degeneration Drug Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Age Related Macular Degeneration Drug Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Age Related Macular Degeneration Drug Sales Market Share Forecast by Countries (2017-2022)
Table Africa Age Related Macular Degeneration Drug Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Age Related Macular Degeneration Drug Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Age Related Macular Degeneration Drug Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Age Related Macular Degeneration Drug Sales Market Share Forecast by Type (2017-2022)
Table EMEA Age Related Macular Degeneration Drug Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Age Related Macular Degeneration Drug Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources